Amphastar Pharmaceuticals Receives FDA Approval for Morphine Sulfate Injection

Amphastar Pharmaceuticals Receives FDA Approval for Morphine Sulfate Injection

datetime
Business Insider
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration (“FDA”) approved the Company’s Abbreviated New Drug Application (“ANDA”) for Morphine Sulfate injection 1mg/mL in the 30mL Pump-Jet ® Prefilled Syringe System.
Business
Read Article